NCT07366281

Brief Summary

The goal of this clinical trial is to evaluate the feasibility, safety, and performance of the new adhesive when used in the immediate post-operative period after total laryngectomy. The main question it aims to answer is: \- Is the adhesive feasible and safe to use during the early post-operative phase? This is a single-arm feasibility study with historical controls, so there is no concurrent comparison group. Researchers will compare outcomes to historical data from standard adhesive use to assess improvements in tolerance and skin condition. Participants will:

  • Use the adhesive as part of their standard post-laryngectomy care.
  • Complete patient-reported outcome questionnaires (e.g., comfort, skin assessment, satisfaction).
  • Allow investigators to record observations in diaries and patient charts.
  • Participate in routine clinical assessments during hospitalization and at end of study (approximately 30 days post-surgery).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Mar 2026Apr 2027

First Submitted

Initial submission to the registry

December 19, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

December 19, 2025

Last Update Submit

January 16, 2026

Conditions

Keywords

Adhesive baseplateTracheostoma carePostoperative stoma management

Outcome Measures

Primary Outcomes (1)

  • Proportion of Participants Able to Use New Adhesive During Postoperative Period

    Ability to use new adhesive continuously during the postoperative period, without discontinuation due to intolerance or complications related to the adhesive. Assessed through patient diary and investigator review.

    From enrollment to the end of treatment at 30 days.

Secondary Outcomes (12)

  • Number of Skin Reactions or Pain/Discomfort Assessed by Investigator and Patient

    From enrollment to the end of treatment at 30 days.

  • Performance: Adhesive Adhesion Performance: Score on 5-Point Adhesion Rating Scale

    From enrollment to the end of treatment at 30 days.

  • Device Life Measured as Hours Adhesive Remains in Place

    From enrollment to the end of treatment at 30 days.

  • Performance: Adequacy of Adhesive Fit Around Stoma on a 5-Point Stoma Fit Scale

    From enrollment to the end of treatment at 30 days.

  • Performance: Ease of Adhesive Application and Removal on 5-Point Ease Scale

    From enrollment to the end of treatment at 30 days.

  • +7 more secondary outcomes

Study Arms (1)

Exploratory post-operative use of Comfort Adhesive

EXPERIMENTAL

Participants will start using a newly developed adhesive called Provox Life Comfort Adhesive in the immediate post-operative period following total laryngectomy.

Device: Provox Life Comfort Adhesive

Interventions

The new Provox Life Comfort adhesive is a medical adhesive baseplate designed for tracheostoma care in laryngectomy patients.

Exploratory post-operative use of Comfort Adhesive

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergoing total laryngectomy surgery
  • years or older

You may not qualify if:

  • Unable to give informed consent prior to TL surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antoni van Leeuwenhoek, Netherlands Cancer Institute

Amsterdam, 1066 CX, Netherlands

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 26, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations